2000
Treatment of Cutaneous Warts With Squaric Acid Dibutylester: A Decade of Experience
Search citation statements
Paper Sections
Select...
30
5
1
0
Citation Types
2
25
1
0
Year Published
2001
2022
Publication Types
Select...
31
2
Relationship
0
33
Authors
Journals
Cited by 33 publications
(28 citation statements)
References 1 publication
2
25
1
0
“…Immunotherapy using an allergic contact sensitizer such as DNCB, squaric acid dibutylester (SADBE), and DPCP is a pain-free treatment that has a relatively high efficacy (45%-88%) based on previous reports and, therefore, is considered an effective treatment method. [2][3][4][5][6][7][8][9][10] In our study, positive clinical responses for DPCP as monotherapy were 75.6%, which are quite similar to the results from previous reports. Most studies of DPCP monotherapy only included patients who had immunotherapy after the failure of conventional treatment.…”
Section: Discussionsupporting
confidence: 90%
“…Immunotherapy using an allergic contact sensitizer such as DNCB, squaric acid dibutylester (SADBE), and DPCP is a pain-free treatment that has a relatively high efficacy (45%-88%) based on previous reports and, therefore, is considered an effective treatment method. [2][3][4][5][6][7][8][9][10] In our study, positive clinical responses for DPCP as monotherapy were 75.6%, which are quite similar to the results from previous reports. Most studies of DPCP monotherapy only included patients who had immunotherapy after the failure of conventional treatment.…”
Section: Discussionsupporting
confidence: 90%
“…Our study noted concurrent skin diseases in patients, as they are occasionally cited as a reason for lack of treatment response. One study mentioned immunosuppression and atopic dermatitis as reasons for nonresponse . Even in our limited patient population, our study suggests no association between atopic dermatitis and response .…”
Section: Discussioncontrasting
confidence: 67%
“…In our study, 83% of the 44 who could be reached for follow‐up reported resolution of their warts. Overall, prior reports of SADBE wart treatment documented response rates ranging from 58% to 84% . The highest reported success rate with SADBE treatment included pretreatment of warts with 70% salicylic acid under occlusion for 2 days, with a resolution rate of 84%; a similar rate was seen in our limited patient population (40 of 48 patients) who were available for follow‐up .…”
Section: Discussionsupporting
confidence: 59%
“…The rate of resolution we obtained treating patients with SADBE was confirmed to be quite high as demonstrated by several uncontrolled studies in which it ranged from 58% to 86%. 7,13,14,16–18 At 52-week follow-up, no recurrences were recorded in any responder patients of either group. Overall, therapy with SADBE was safe and well tolerated.…”
Section: Discussionmentioning
confidence: 88%
